Journal article

Publication year: 2006

Pages: 987-997

Journal: European Urology

Volume number: 49

Issue number: 6

ISSN: 0302-2838

eISSN: 1873-7560

DOI Link: https://doi.org/10.1016/j.eururo.2006.02.059

Publisher: Elsevier

Abstract: 

Objective: Because the efficacy of nonsurgical therapy of Peyronie's disease is controversial, this review analyses the current status of conservative therapy of Peyronie's disease.

Method: A systematic survey on results of studies published as original papers in peer-reviewed journals is provided.

Results: Oral drug therapies include potassium para-aminobenzoate (Potaba), vitamin E, colchicine, tamoxifen, propoleum, acetyl-L-carnitine, and propionyl-L-carnitine. Verapamil, interferon-alpha 2a and interferon-alpha 2b, collagenase, cortisone, hyaluronidase, and superoxide dismutase are considered intralesional therapies that have had various degrees of success. other treatments include local gels, iontophoresis, extracorporeal shock wave therapy, and radiation.

Conclusion: This review analyses the current status of the conservative therapy of Peyronie's disease, because the efficacy of the nonsurgical therapy is controversial. (c) 2006 Elsevier B.V. All rights reserved.

Harvard Citation style: Hauck, E., Diemer, T., Schmelz, H. and Weidner, W. (2006) A critical analysis of nonsurgical treatment of Peyronie's disease, European Urology, 49(6), pp. 987-997. https://doi.org/10.1016/j.eururo.2006.02.059

APA Citation style: Hauck, E., Diemer, T., Schmelz, H., & Weidner, W. (2006). A critical analysis of nonsurgical treatment of Peyronie's disease. European Urology. 49(6), 987-997. https://doi.org/10.1016/j.eururo.2006.02.059